vs

Side-by-side financial comparison of Oncology Institute, Inc. (TOI) and Turning Point Brands, Inc. (TPB). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $121.0M, roughly 1.2× Turning Point Brands, Inc.). Turning Point Brands, Inc. runs the higher net margin — 6.8% vs -5.3%, a 12.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 29.2%). Turning Point Brands, Inc. produced more free cash flow last quarter ($21.5M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 20.7%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

Turning Point Australia (TPAUS) is a conservative lobby group based in Australia, affiliated with Turning Point USA but independent of it. Founded by Joel Jammal and first registered in 2023, the group has become active in trying to influence the outcome of the 2026 South Australian state election in March 2026.

TOI vs TPB — Head-to-Head

Bigger by revenue
TOI
TOI
1.2× larger
TOI
$142.0M
$121.0M
TPB
Growing faster (revenue YoY)
TOI
TOI
+12.4% gap
TOI
41.6%
29.2%
TPB
Higher net margin
TPB
TPB
12.1% more per $
TPB
6.8%
-5.3%
TOI
More free cash flow
TPB
TPB
$19.3M more FCF
TPB
$21.5M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
20.7%
TPB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TOI
TOI
TPB
TPB
Revenue
$142.0M
$121.0M
Net Profit
$-7.5M
$8.2M
Gross Margin
55.9%
Operating Margin
-4.9%
16.5%
Net Margin
-5.3%
6.8%
Revenue YoY
41.6%
29.2%
Net Profit YoY
43.0%
239.8%
EPS (diluted)
$-0.04
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TOI
TOI
TPB
TPB
Q4 25
$142.0M
$121.0M
Q3 25
$136.6M
$119.0M
Q2 25
$119.8M
$116.6M
Q1 25
$104.4M
$106.4M
Q4 24
$100.3M
$93.7M
Q3 24
$99.9M
$90.7M
Q2 24
$98.6M
$93.2M
Q1 24
$94.7M
$83.1M
Net Profit
TOI
TOI
TPB
TPB
Q4 25
$-7.5M
$8.2M
Q3 25
$-16.5M
$21.1M
Q2 25
$-17.0M
$14.5M
Q1 25
$-19.6M
$14.4M
Q4 24
$-13.2M
$2.4M
Q3 24
$-16.1M
$12.4M
Q2 24
$-15.5M
$13.0M
Q1 24
$-19.9M
$12.0M
Gross Margin
TOI
TOI
TPB
TPB
Q4 25
55.9%
Q3 25
59.2%
Q2 25
57.1%
Q1 25
56.0%
Q4 24
56.0%
Q3 24
55.6%
Q2 24
54.1%
Q1 24
58.2%
Operating Margin
TOI
TOI
TPB
TPB
Q4 25
-4.9%
16.5%
Q3 25
-5.9%
21.8%
Q2 25
-9.4%
22.6%
Q1 25
-9.5%
21.8%
Q4 24
-11.9%
19.1%
Q3 24
-13.9%
22.9%
Q2 24
-16.6%
24.5%
Q1 24
-19.0%
23.2%
Net Margin
TOI
TOI
TPB
TPB
Q4 25
-5.3%
6.8%
Q3 25
-12.1%
17.7%
Q2 25
-14.2%
12.4%
Q1 25
-18.8%
13.5%
Q4 24
-13.1%
2.6%
Q3 24
-16.1%
13.6%
Q2 24
-15.7%
14.0%
Q1 24
-21.0%
14.5%
EPS (diluted)
TOI
TOI
TPB
TPB
Q4 25
$-0.04
$0.40
Q3 25
$-0.14
$1.13
Q2 25
$-0.15
$0.79
Q1 25
$-0.21
$0.79
Q4 24
$-0.14
$0.15
Q3 24
$-0.18
$0.68
Q2 24
$-0.17
$0.68
Q1 24
$-0.22
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TOI
TOI
TPB
TPB
Cash + ST InvestmentsLiquidity on hand
$222.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-15.7M
$372.0M
Total Assets
$164.7M
$763.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TOI
TOI
TPB
TPB
Q4 25
$222.8M
Q3 25
$201.2M
Q2 25
$109.9M
Q1 25
$99.6M
Q4 24
$48.9M
Q3 24
$33.6M
Q2 24
$9.9M
$142.2M
Q1 24
$29.8M
$130.9M
Stockholders' Equity
TOI
TOI
TPB
TPB
Q4 25
$-15.7M
$372.0M
Q3 25
$-12.3M
$358.2M
Q2 25
$-9.0M
$224.8M
Q1 25
$5.1M
$203.4M
Q4 24
$3.6M
$190.4M
Q3 24
$15.5M
$185.7M
Q2 24
$29.2M
$172.8M
Q1 24
$41.3M
$160.0M
Total Assets
TOI
TOI
TPB
TPB
Q4 25
$164.7M
$763.8M
Q3 25
$163.6M
$742.8M
Q2 25
$159.8M
$595.8M
Q1 25
$164.0M
$564.6M
Q4 24
$172.7M
$493.4M
Q3 24
$179.2M
$488.0M
Q2 24
$179.6M
$591.6M
Q1 24
$204.5M
$586.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TOI
TOI
TPB
TPB
Operating Cash FlowLast quarter
$3.2M
$24.9M
Free Cash FlowOCF − Capex
$2.2M
$21.5M
FCF MarginFCF / Revenue
1.5%
17.8%
Capex IntensityCapex / Revenue
0.7%
2.8%
Cash ConversionOCF / Net Profit
3.03×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TOI
TOI
TPB
TPB
Q4 25
$3.2M
$24.9M
Q3 25
$-12.6M
$3.3M
Q2 25
$-10.2M
$11.8M
Q1 25
$-5.0M
$17.4M
Q4 24
$4.2M
$17.7M
Q3 24
$819.0K
$13.2M
Q2 24
$-15.7M
$13.4M
Q1 24
$-15.9M
$22.6M
Free Cash Flow
TOI
TOI
TPB
TPB
Q4 25
$2.2M
$21.5M
Q3 25
$-13.2M
$-721.0K
Q2 25
$-11.4M
$7.8M
Q1 25
$-5.3M
$15.2M
Q4 24
$2.4M
$16.6M
Q3 24
$417.0K
$12.6M
Q2 24
$-17.5M
$10.9M
Q1 24
$-16.5M
$22.3M
FCF Margin
TOI
TOI
TPB
TPB
Q4 25
1.5%
17.8%
Q3 25
-9.7%
-0.6%
Q2 25
-9.5%
6.7%
Q1 25
-5.1%
14.3%
Q4 24
2.4%
17.8%
Q3 24
0.4%
13.9%
Q2 24
-17.7%
11.7%
Q1 24
-17.4%
26.8%
Capex Intensity
TOI
TOI
TPB
TPB
Q4 25
0.7%
2.8%
Q3 25
0.4%
3.4%
Q2 25
1.0%
3.4%
Q1 25
0.3%
2.1%
Q4 24
1.8%
1.2%
Q3 24
0.4%
0.7%
Q2 24
1.9%
2.7%
Q1 24
0.6%
0.4%
Cash Conversion
TOI
TOI
TPB
TPB
Q4 25
3.03×
Q3 25
0.16×
Q2 25
0.82×
Q1 25
1.21×
Q4 24
7.34×
Q3 24
1.07×
Q2 24
1.03×
Q1 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

TPB
TPB

US$111.5M92%
Non Us$9.6M8%

Related Comparisons